A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Pfizer Inc stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 120,468 shares of PFE stock, worth $3.44 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
120,468
Previous 122,678 1.8%
Holding current value
$3.44 Million
Previous $6.35 Million 0.55%
% of portfolio
0.75%
Previous 0.64%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$46.53 - $55.17 $102,831 - $121,925
-2,210 Reduced 1.8%
120,468 $6.32 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $344,772 - $427,215
7,536 Added 6.54%
122,678 $6.35 Million
Q4 2021

Jan 10, 2022

BUY
$41.32 - $61.25 $586,248 - $869,015
14,188 Added 14.05%
115,142 $6.8 Million
Q3 2021

Oct 19, 2021

SELL
$39.25 - $50.42 $345,792 - $444,200
-8,810 Reduced 8.03%
100,954 $4.34 Million
Q2 2021

Aug 23, 2021

SELL
$35.91 - $40.68 $545,329 - $617,766
-15,186 Reduced 12.15%
109,764 $4.3 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $152,647 - $172,155
-4,558 Reduced 3.52%
124,950 $4.53 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $619,760 - $727,120
-19,520 Reduced 13.1%
129,508 $4.75 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $293,639 - $356,228
9,749 Added 7.0%
149,028 $5.82 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $23,975 - $34,255
-887 Reduced 0.63%
139,279 $4.55 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $479,809 - $544,522
-14,575 Reduced 9.42%
140,166 $5.49 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $30,833 - $39,981
949 Added 0.62%
154,741 $5.56 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $210,194 - $235,999
5,684 Added 3.84%
153,792 $6.66 Million
Q1 2019

May 17, 2019

BUY
$37.5 - $41.2 $184,012 - $202,168
4,907 Added 3.43%
148,108 $6.29 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $51,395 - $58,596
1,336 Added 0.94%
143,201 $6.25 Million
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $58,771 - $71,286
1,705 Added 1.22%
141,865 $6.25 Million
Q2 2018

Jul 25, 2018

BUY
$32.98 - $35.16 $517,950 - $552,187
15,705 Added 12.62%
140,160 $5.09 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $195,002 - $226,229
-6,111 Reduced 4.68%
124,455 $4.42 Million
Q4 2017

Feb 20, 2018

BUY
$33.26 - $35.29 $64,025 - $67,933
1,925 Added 1.5%
130,566 $4.73 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $3.99 Million - $4.39 Million
128,641
128,641 $4.59 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.